Literature DB >> 2448793

Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule.

M F Good1, D Pombo, I A Quakyi, E M Riley, R A Houghten, A Menon, D W Alling, J A Berzofsky, L H Miller.   

Abstract

The definition of human T-cell antigenic sites is important for subunit vaccine development of a peptide immunogen if the goal is to allow antibody boosting during infection or to stimulate antibody-independent T-cell immunity. To identify such sites on the circumsporozoite (CS) protein of Plasmodium falciparum, 29 overlapping synthetic peptides spanning the entire CS protein were made and tested for their ability to stimulate peripheral blood lymphocytes from 35 adults living in a P. falciparum malaria-endemic region of West Africa. Three immunodominant domains were located outside the repetitive region. These domains, however, occurred in the polymorphic regions of the molecule, suggesting that parasite mutation and selection has occurred in response to immune pressure from T cells. Such polymorphism may impose an obstacle for vaccine development.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2448793      PMCID: PMC279734          DOI: 10.1073/pnas.85.4.1199

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

Authors:  R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

2.  Sequence variation in putative functional domains of the circumsporozoite protein of Plasmodium falciparum. Implications for vaccine development.

Authors:  V F de la Cruz; A A Lal; T F McCutchan
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

Review 3.  Protein antigenic structures recognized by T cells: potential applications to vaccine design.

Authors:  J A Berzofsky; K B Cease; J L Cornette; J L Spouge; H Margalit; I J Berkower; M F Good; L H Miller; C DeLisi
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

4.  CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites.

Authors:  W R Weiss; M Sedegah; R L Beaudoin; L H Miller; M F Good
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

5.  The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.

Authors:  G Del Giudice; J A Cooper; J Merino; A S Verdini; A Pessi; A R Togna; H D Engers; G Corradin; P H Lambert
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

6.  A blood stage antigen of Plasmodium falciparum shares determinants with the sporozoite coat protein.

Authors:  R L Coppel; J M Favaloro; P E Crewther; T R Burkot; A E Bianco; H D Stahl; D J Kemp; R F Anders; G V Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

7.  Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein.

Authors:  M F Good; W L Maloy; M N Lunde; H Margalit; J L Cornette; G L Smith; B Moss; L H Miller; J A Berzofsky
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

8.  Strong conformational propensities enhance T cell antigenicity.

Authors:  J L Spouge; H R Guy; J L Cornette; H Margalit; K Cease; J A Berzofsky; C DeLisi
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

9.  The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins.

Authors:  J Lawler; R O Hynes
Journal:  J Cell Biol       Date:  1986-11       Impact factor: 10.539

10.  Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection.

Authors:  P Potocnjak; N Yoshida; R S Nussenzweig; V Nussenzweig
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

View more
  72 in total

Review 1.  Molecular parasitology: progress towards the development of vaccines for malaria, filariasis, and schistosomiasis.

Authors:  S J Cryz
Journal:  Experientia       Date:  1991-02-15

Review 2.  Immune responses to sporozoite antigens and their relationship to naturally acquired immunity to malaria.

Authors:  B M Greenwood
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

3.  HLA-A2 supertype-restricted cell-mediated immunity by peripheral blood mononuclear cells derived from Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls.

Authors:  Kirsten E Lyke; Robin B Burges; Yacouba Cissoko; Lansana Sangare; Abdoulaye Kone; Modibo Dao; Issa Diarra; Marcelo A Fernández-Vina; Christopher V Plowe; Ogobara K Doumbo; Marcelo B Sztein
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein.

Authors:  Michael Walther; Fiona M Thompson; Susanna Dunachie; Sheila Keating; Stephen Todryk; Tamara Berthoud; Laura Andrews; Rikke F Andersen; Anne Moore; Sarah C Gilbert; Ian Poulton; Filip Dubovsky; Eveline Tierney; Simon Correa; Angela Huntcooke; Geoffrey Butcher; Jack Williams; Robert E Sinden; Adrian V S Hill
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 5.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

6.  Evidence implicating MHC genes in the immunological nonresponsiveness to the Plasmodium falciparum CS protein.

Authors:  M F Good; S Kumar; A S De Groot; W R Weiss; I A Quakyi; F Dontfraid; G E Smith; M Cochran; J A Berzofsky; L H Miller
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

Review 7.  The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite?

Authors:  L Schofield
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

8.  Mapping T-cell epitopes in group A streptococcal type 5 M protein.

Authors:  J H Robinson; M C Atherton; J A Goodacre; M Pinkney; H Weightman; M A Kehoe
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

9.  T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine development.

Authors:  M H Gatei; M F Good; R C Daniel; M F Lavin
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.

Authors:  M H Gatei; H M Naif; S Kumar; D B Boyle; R C Daniel; M F Good; M F Lavin
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.